Artelo Biosciences earnings were -$13.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ARTL earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$3.0M, down 29% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ARTL reported annual earnings of -$12.9M, with 31.1% growth. The next ARTL earnings date is Aug 12, 2026.
What were Artelo Biosciences's earnings last quarter?
Artelo Biosciences (NASDAQ: ARTL) reported Q1 2026 earnings per share (EPS) of -$4.00, up 68.13% year over year. Total ARTL earnings for the quarter were -$2.96 million. In the same quarter last year, Artelo Biosciences's earnings per share (EPS) was -$12.55.
The next ARTL earnings call is Aug 12, 2026. Add ARTL to your watchlist to be reminded of Artelo Biosciences's next earnings date.
What was ARTL's earnings growth in the past year?
As of Artelo Biosciences's earnings date in Q3 2026, Artelo Biosciences's earnings has grown year over year. ARTL earnings in the past year totalled -$13.47 million.
Is Artelo Biosciences profitable or losing money?
As of the last Artelo Biosciences earnings report, Artelo Biosciences is currently losing money. Artelo Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$13.47 million, a 38.6% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.